Genomic newborn screening: ICoNS

Gene: BCKDHB

Green List (high evidence)

BCKDHB (branched chain keto acid dehydrogenase E1 subunit beta)
EnsemblGeneIds (GRCh38): ENSG00000083123
EnsemblGeneIds (GRCh37): ENSG00000083123
OMIM: 248611, ClinGen, DECIPHER
BCKDHB is in 15 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Discussed at Gene list subcommittee meeting 13/03/26: included in RUSP and now included by most studies, including in latest BeginNGS list (previous outlier).
Created: 13 Mar 2026, 7:16 a.m. | Last Modified: 13 Mar 2026, 7:16 a.m.
Panel Version: 0.29

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Maple syrup urine disease, type Ib, MIM# 248600

José Manuel González de Aledo Castillo (Other)

Gene disease association evidence:

Disease: Maple syrup urine disease type 1A (MSUD1B), autosomal recessive.
Gene: BCKDHB encodes the E1β subunit of the branched-chain α-ketoacid dehydrogenase complex. Loss of function at the protein level reduces BCKD activity and causes toxic accumulation of branched-chain amino acids and ketoacids. BCKDHB variants account for ~35% of MSUD cases

Curation by ClinGen:
ClinGen gene–disease validity: Definitive

Treatability and evidence behind that including impact of treatment:
Standard care is dietary leucine restriction, BCAA-free supplements, supplementation with isoleucine and valine as needed, and frequent biochemical monitoring. Acute metabolic crises need urgent metabolic management.
Early treatment of asymptomatic infants detected by NBS means that most who would have developed neonatal manifestations remain asymptomatic with good treatment adherence . NBS cases has better survival than clinically diagnosed cases: 62.5% versus 5.2%
For severe MSUD, liver transplantation can be an option

Issues with genomic screening
Main problem would be turnaround time

Any variants of interest
The pathogenic spectrum is dominated by missense variants, also there also reported truncating variants.
c.548G>C (p.Arg183Pro): well-known Ashkenazi Jewish founder variant.

Who has excluded in genomic newborn screening it and why:
BeginNGS in previous genelists, now included

Traditional newborn screening in any jurisdiction:
Included in RUSP and most NBS wordlwide
Sources: Expert Review, Literature
Created: 12 Mar 2026, 9:40 p.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

History Filter Activity

13 Mar 2026, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: bckdhb has been classified as Green List (High Evidence).

13 Mar 2026, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

Phenotypes for gene: BCKDHB were changed from to Maple syrup urine disease, type Ib, MIM# 248600

13 Mar 2026, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: bckdhb has been classified as Green List (High Evidence).

12 Mar 2026, Gel status: 0

Created, Added New Source, Set mode of inheritance

José Manuel González de Aledo Castillo (Other)

gene: BCKDHB was added gene: BCKDHB was added to Genomic newborn screening: ICoNS. Sources: Expert Review,Literature Mode of inheritance for gene: BCKDHB was set to BIALLELIC, autosomal or pseudoautosomal